# ORAL T-8 Oral Testosterone for Male Hormonal Contraception

> **NCT01167829** · PHASE1 · COMPLETED · sponsor: **University of Washington** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Oral Testosterone
- **DRUG:** Acyline

## Key facts

- **NCT ID:** NCT01167829
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2010-10
- **Final completion:** 2012-06
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2013-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01167829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01167829, "ORAL T-8 Oral Testosterone for Male Hormonal Contraception". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01167829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*